Literature DB >> 35401954

Characteristics and attitudes of first round invitees in the Irish National Colorectal Cancer Screening Programme.

Susanne M O'Reilly1, Katie N Hughes1, Therese Mooney2, Patricia Fitzpatrick2, Diarmuid O'Donoghue1,3, Sara McNally2, Mary Codd4, Elizabeth Ryan1, Glen Doherty1, Olivia Mason4, Hugh E Mulcahy1, Garret Cullen1.   

Abstract

Background/objective: Colorectal cancer (CRC) screening is proven to reduce CRC-related mortality. Faecal immunochemical testing (FIT)-positive clients in the Irish National CRC Screening Programme underwent colonoscopy. Round 1 uptake was 40.2%. We sought to identify barriers to participation by assessing knowledge of CRC screening and examining attitudes towards FIT test and colonoscopy.
Methods: Questionnaires based on a modified Champion's Health Belief Model were mailed to 3500 invitees: 1000 FIT-positive, 1000 FIT-negative and 1500 non-participants. 44% responded: 550 (46%) FIT-positive, 577 (48%) FIT-negative and 69 (6%) non-responders (NR).
Results: 25% of respondents (n=286) did not perceive a personal risk of cancer, did not perceive CRC to be a serious disease and did not perceive benefits to screening. These opinions were more likely to be expressed by men (p=0.035). One-fifth (n=251) found screening stressful. Fear of cancer diagnosis and test results were associated with stress. FIT-positive clients, women and those with social medical insurance were more likely to experience stress. Conclusions: The CRC screening process causes stress to one-fifth of participants. Greater use of media and involvement of healthcare professionals in disseminating information on the benefits of screening may lead to higher uptake in round 2. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  colorectal cancer; colorectal cancer screening; screening

Year:  2020        PMID: 35401954      PMCID: PMC8989011          DOI: 10.1136/flgastro-2020-101417

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  24 in total

1.  Promoting preventive health screening through the use of a clinical reminder tool: an accountable care organization quality improvement initiative.

Authors:  Crystal Wilkinson; Jane Dimmitt Champion; Karen Sabharwal
Journal:  J Healthc Qual       Date:  2013 Sep-Oct       Impact factor: 1.095

Review 2.  Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model.

Authors:  Crista E Johnson; Katherine E Mues; Stephanie L Mayne; Ava N Kiblawi
Journal:  J Low Genit Tract Dis       Date:  2008-07       Impact factor: 1.925

3.  Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.

Authors:  Cédric Rat; Corinne Pogu; Delphine Le Donné; Chloé Latour; Gaelle Bianco; France Nanin; Anne Cowppli-Bony; Aurélie Gaultier; Jean-Michel Nguyen
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

4.  Participation rates for organized colorectal cancer screening programmes: an international comparison.

Authors:  Carrie Klabunde; Johannes Blom; Jean-Luc Bulliard; Montse Garcia; Lea Hagoel; Verna Mai; Julietta Patnick; Heather Rozjabek; Carlo Senore; Sven Törnberg
Journal:  J Med Screen       Date:  2015-05-12       Impact factor: 2.136

5.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

Authors:  J S Mandel; T R Church; F Ederer; J H Bond
Journal:  J Natl Cancer Inst       Date:  1999-03-03       Impact factor: 13.506

6.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

7.  Effect of screening colonoscopy on colorectal cancer incidence and mortality.

Authors:  Charles J Kahi; Thomas F Imperiale; Beth E Juliar; Douglas K Rex
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-11       Impact factor: 11.382

8.  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Authors:  L Hol; M E van Leerdam; M van Ballegooijen; A J van Vuuren; H van Dekken; J C I Y Reijerink; A C M van der Togt; J D F Habbema; E J Kuipers
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

9.  Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study.

Authors:  C K Palmer; M C Thomas; C von Wagner; R Raine
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

10.  Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.

Authors:  Wendy Atkin; Kate Wooldrage; D Maxwell Parkin; Ines Kralj-Hans; Eilidh MacRae; Urvi Shah; Stephen Duffy; Amanda J Cross
Journal:  Lancet       Date:  2017-02-22       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.